Rosewind Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Rosewind Corp
TickerAYTU
CIK #0001385818
CUSIP054754858
SectorTrade & Services - Services-Educational Services
Address16200 Wcr 18E, Loveland, CO 80537
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Aytu Bioscience Inc 2019-10-31 10.0 M Exemption: 506(b) · Duration: One year or less · Commission: $800,000 · Revenue: Decline to Disclose
Rosewind Corp 2011-02-04 0.0 M Exemption: 505 · Minimum: $250 · Remaining: Indefinite · Duration: One year or less · Revenue: $1 - $1,000,000
CIK Filing 2011 - 2026
[0001385818] 10-K
[0001385818] 10-Q
[0001385818] 3
[0001385818] 4
[0001385818] 5
[0001385818] 8-K
[0001385818] D
[0001385818] SC 13D
[0001385818] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
AWM Investment Company Inc Aytu Biopharma Inc [2025-08-14] 0.0
Philotimo Fund LP Aytu Biopharma Inc [2025-06-26] 0.0
Philotimo Fund LP Aytu Biopharma Inc [2025-06-26] 0.0
Lytton Laurence W Aytu Biopharma Inc [2025-06-13] 0.0
Stonepine Capital Management LLC Aytu Biopharma Inc [2023-06-16] 0.99
Nantahala Capital Management LLC Aytu Biopharma Inc [2023-05-26] 7.2
CVI Investments Inc Aytu Biopharma Inc [2022-08-15] 5.6
Integrated Core Strategies US LLC Aytu Biopharma Inc [2021-03-26] 0.0
Armistice Capital LLC Aytu Bioscience Inc [2020-12-21] 7.7
Stonepine Capital Management LLC Aytu Bioscience Inc [2020-12-17] 7.7
Cerecor Inc Aytu Bioscience Inc [2020-04-27] 0.0
Intracoastal Capital LLC Aytu Bioscience Inc [2020-03-23] 3.7
Sabby Management LLC Aytu Bioscience Inc [2020-03-12] 0.0
Altium Capital Management LP Aytu Bioscience Inc [2019-10-21] 9.9
UBS Group AG Aytu Bioscience Inc [2019-03-08] 16.14
Armistice Capital LLC Aytu Bioscience Inc [2019-02-15] 16.1
Hudson Bay Capital Management LP Aytu Bioscience Inc [2019-02-01] 8.37
CVI Investments Inc Aytu Bioscience Inc [2018-10-12] 0.9
Highbridge Capital Management LLC Aytu Bioscience Inc [2018-03-12] 7.91
Bigger Capital Fund L P Aytu Bioscience Inc [2018-03-08] 7.4
Empery Asset Management LP Aytu Bioscience Inc [2018-03-06] 0.38
Galileo Partners LLC Aytu Bioscience Inc [2018-02-12] 5.6
Armistice Capital LLC Aytu Bioscience Inc [2017-08-24] 0.99
Manchester Management Co LLC Aytu Bioscience Inc [2017-08-23] 4.6
Galileo Partners LLC Aytu Bioscience Inc [2017-05-12] 7.8
Sabby Management LLC Aytu Bioscience Inc [2016-11-15] 3.07
Alpha Venture Capital Partners LP Aytu Bioscience Inc [2016-05-19] 11.3
Ampio Pharmaceuticals Inc Rosewind Corp [2015-04-24] 81.5
Form 3/4/5 Filer 2011 - 2026
Dockery Carl
Aytu Biopharma Inc
Pyszczymuka Greg
Liu Vivian H
Disbrow Joshua R
Selhorn Ryan J
Disbrow Jarrett
Donofrio John Jr
Jain Abhinav
Nantahala Capital Management LLC
Harkey Wilmot B
Mack Daniel
Oki Mark K
Brooke Christopher
Cantrell Gary
Armistice Capital Master Fund Ltd
Boyd Steven
Armistice Capital LLC
Macaluso Michael
Hecht Beth
McLaughlin Gerald W
Eisenstadt Richard I
Green David A
Mehta Ketan Bhupatrai
Avalo Therapeutics Inc
Gould Gregory A
McGrael Jonathan H
Ampio Pharmaceuticals Inc
Wiegand James B
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Dockery Carl
Common Stock
2025-10-03 Grant 10,000 $0.00
Donofrio John Jr
Common Stock
2025-10-03 Grant 10,000 $0.00
Pyszczymuka Greg
Common Stock
2025-10-03 Grant 12,500 $0.00
Disbrow Jarrett
Common Stock
2025-10-03 Grant 12,500 $0.00
Disbrow Jarrett
Common Stock
2025-10-03 Grant 19,606 $0.00
Selhorn Ryan J
Common Stock
2025-10-03 Grant 16,243 $0.00
Selhorn Ryan J
Common Stock
2025-10-03 Grant 17,500 $0.00
Disbrow Joshua R
Common Stock
2025-10-03 Grant 31,446 $0.00
Disbrow Joshua R
Common Stock
2025-10-03 Grant 22,500 $0.00
Liu Vivian H
Common Stock
2025-10-03 Grant 10,000 $0.00
Jain Abhinav
Common Stock
2025-10-03 Grant 10,000 $0.00
Disbrow Jarrett
Common Stock
2025-06-09 Buy 16,666 $1.50 24,999
Disbrow Joshua R
Common Stock
2025-06-09 Buy 66,666 $1.50 99,999
Nantahala Capital Management LLC +2
Prefunded Warrants · derivative
2025-06-06 Buy 4,000,000 $1.50 6,000,000
Pyszczymuka Greg
Common Shares
2025-03-31 Option exercise 209
Pyszczymuka Greg
Restricted Stock Units · derivative
2025-03-31 Option exercise 209 $0.00
Disbrow Joshua R
Common Stock
2025-02-28 Buy 15,000 $1.30 19,500
Selhorn Ryan J
Restricted Stock Units · derivative
2025-02-05 Option exercise 105 $0.00
Selhorn Ryan J
Common Shares
2025-02-05 Option exercise 105
Pyszczymuka Greg
Common Shares
2024-12-31 Option exercise 208
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 37 3,903,299
2025-12-31 39 3,739,953
2025-09-30 33 3,580,384
2025-06-30 33 3,380,297
2025-03-31 32 1,876,608
2024-12-31 30 1,880,742
2024-09-30 25 2,048,613
2024-06-30 29 3,222,756
2024-03-31 28 1,798,205
2023-12-31 24 2,945,955
2023-09-30 23 1,725,147
2023-06-30 22 1,704,503
Form 13F Holdings
Firm Period DFND Voting Shares
FNY Investment Advisers LLC [2026-06-30] SOLE 110 110
Farther Finance Advisors LLC [2026-06-30] SOLE 0 4
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com